BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+46.8%
5Y CAGR+26.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+46.8%/yr
vs -1.8%/yr prior
5Y CAGR
+26.1%/yr
Recent acceleration
Acceleration
+48.6pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 26.56% |
| 2024 | 13.07% |
| 2023 | 8.41% |
| 2022 | 8.40% |
| 2021 | 2.94% |
| 2020 | 8.34% |
| 2019 | 12.66% |
| 2018 | 9.03% |
| 2017 | 16.31% |
| 2016 | 18.48% |